Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer.
Kalinsky K, Sparano J, Kim M, Crew K, Maurer M, Taback B, Feldman S, Hibshoosh H, Wiechmann L, Adelson K, Hershman D. Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer. Journal Of Clinical Oncology 2011, 29: tps147-tps147. DOI: 10.1200/jco.2011.29.15_suppl.tps147.Peer-Reviewed Original Research